MEDLAB Middle East 2021 Brings World of Laboratory Medicine Together Under ‘United by Business’ Show Theme
By LabMedica International staff writers Posted on 21 Jun 2021 |

Illustration
The 2021 edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, took place at the Dubai World Trade Centre from 21-24 June, bringing the global healthcare community together under the show theme of ‘United by Business’.
A host of countries, including the UK, Germany, Austria, Belgium, Israel, Korea, Poland, Spain and the US, participated in the event. A range of key laboratory and trade professionals from across the region attended the live and in-person event. It featured a range of keynote speeches and scientific lectures, industry briefings, product demonstrations and networking opportunities, as well as a series of pre-arranged one-to-one meetings, with an emphasis on creating lasting relationships.
Underscoring the confidence within the industry and the increased demand from laboratory professionals to participate in a physical event, several companies and health authorities exhibited at the event. These included the UAE Ministry for Health and Prevention, the College of American Pathologists, Abbott Laboratories, Horiba, Randox Laboratories, Euroimmun, BioVender Group, Seegene, Stago and Erba Group.
Similar to last year, before travel restrictions and country-wide lockdowns, the event attracted over 23,000 professional visitors from over 140 countries and over 3,800 delegates. A total of 14 country pavilions were present at the 2021 edition of the show. The event featured eight Continuing Medical Education (CME) conferences during the live and in-person event and as part of the show's online element. New to the 2021 conference program was a dedicated focus on COVID-19 which addressed the latest scientific findings on the virus and discussed its impact on health in the region.
These were complemented by returning accredited conferences: Laboratory Management, Clinical Chemistry, Clinical Microbiology, Histopathology, Molecular & Genomic Diagnostics, Haematology and Blood Transfusion. A series of medical speciality days have also been scheduled, with experts presenting the latest advancements in specific clinical specialties, including multi-omics, genetics, and stem cells. Medlab Middle East also hosted a range of dedicated online focus days until July 22 to allow participants to continue to do business as well as featured over 180 educational sessions to choose from. The online event platform for both Arab Health and Medlab Middle East was launched on 23 May and will remain available until 22 July.
A host of countries, including the UK, Germany, Austria, Belgium, Israel, Korea, Poland, Spain and the US, participated in the event. A range of key laboratory and trade professionals from across the region attended the live and in-person event. It featured a range of keynote speeches and scientific lectures, industry briefings, product demonstrations and networking opportunities, as well as a series of pre-arranged one-to-one meetings, with an emphasis on creating lasting relationships.
Underscoring the confidence within the industry and the increased demand from laboratory professionals to participate in a physical event, several companies and health authorities exhibited at the event. These included the UAE Ministry for Health and Prevention, the College of American Pathologists, Abbott Laboratories, Horiba, Randox Laboratories, Euroimmun, BioVender Group, Seegene, Stago and Erba Group.
Similar to last year, before travel restrictions and country-wide lockdowns, the event attracted over 23,000 professional visitors from over 140 countries and over 3,800 delegates. A total of 14 country pavilions were present at the 2021 edition of the show. The event featured eight Continuing Medical Education (CME) conferences during the live and in-person event and as part of the show's online element. New to the 2021 conference program was a dedicated focus on COVID-19 which addressed the latest scientific findings on the virus and discussed its impact on health in the region.
These were complemented by returning accredited conferences: Laboratory Management, Clinical Chemistry, Clinical Microbiology, Histopathology, Molecular & Genomic Diagnostics, Haematology and Blood Transfusion. A series of medical speciality days have also been scheduled, with experts presenting the latest advancements in specific clinical specialties, including multi-omics, genetics, and stem cells. Medlab Middle East also hosted a range of dedicated online focus days until July 22 to allow participants to continue to do business as well as featured over 180 educational sessions to choose from. The online event platform for both Arab Health and Medlab Middle East was launched on 23 May and will remain available until 22 July.
Latest MEDLAB 2021 News
- Ortho Exhibits VITROS Range of Diagnostic Testing and Automation Solutions at MEDLAB Middle East 2021
- MP Biomedicals Exhibits Diagnostics Kits and Sample Prep Solutions at MEDLAB Middle East 2021
- BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021
- Diagnostica Stago Highlights Max Generation Family of Coagulation Analyzers at MEDLAB Middle East 2021
- Randox Showcases Latest Product Portfolio and Services at MEDLAB Middle East 2021
- Horiba Medical Exhibits New Generation of Automated Hematology Analyzers at MEDLAB Middle East 2021
- Rad Source Technologies Introduces Premier X-Ray Blood Irradiator RS 3400 at MEDLAB Middle East 2021
- Nova Biomedical Showcases Advanced Point-of-Care Capillary Blood Analyzers at MEDLAB Middle East 2021
- Erba Mannheim Showcases Exciting New Introductions at MEDLAB Middle East 2021
- Bioperfectus Presents Advanced Infectious Disease Diagnostic Solutions at MEDLAB Middle East 2021
- PerkinElmer Demonstrates High-Throughput MSMS Dried Blood Spot Screening Solutions at Medlab Middle East 2021
- PerkinElmer’s EUROIMMUN Presents Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics
- LumiraDx Highlights Next-Generation Point of Care Solutions at MEDLAB Middle East Virtual Event
- Quidel Showcases Comprehensive Suite of COVID-19 Testing Solutions at MEDLAB Middle East 2021
Channels
Clinical Chemistry
view channel
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more
Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read moreMolecular Diagnostics
view channel
Genetic Test Could Predict Poor Outcomes in Lung Transplant Patients
Organ transplantation has dramatically transformed the management of patients suffering from organ failure. Yet, the immune system of the recipient often perceives the transplanted organ as a foreign entity,... Read more
Breakthrough Blood Test Enables Early Pancreatic Cancer Detection
Pancreatic cancer ranks as the fourth-leading cause of cancer-related deaths in the United States. At present, there are no molecular tools available for the early detection of this disease.... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
Current tuberculosis (TB) tests face major limitations when it comes to accurately diagnosing the infection in individuals living with HIV. HIV, a frequent co-infection with TB, complicates detection by... Read more
Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
Critically ill patients in medical intensive care units (MICUs) often suffer from conditions such as acute respiratory distress syndrome (ARDS) or sepsis, which are linked to reduced diversity of gut microbiota... Read more
Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
Urinary tract infections (UTIs) represent a massive burden on patients and healthcare systems. There are over 400 million UTI cases globally each year, of which around 90% are in women. Fast and accurate... Read more
POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read morePathology
view channel
Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
Saliva is one of the most accessible biological fluids, yet it remains underutilized in clinical practice. While saliva samples are used to perform genetic tests to determine, for example, paternity, the... Read moreTechnology
view channel
New POC Biosensing Technology Improves Detection of Molecular Biomarkers
Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more
Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey
Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists.... Read moreIndustry
view channel
AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more